🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines ◆
Updated 21 Aug 2026 · ClinicalTrials.gov

Clinical Trials in Kentucky

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

17
Recruiting now
21
Studies tracked
Kentucky
Selected state
Recruiting Phase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Amgen · started 2023-11-16
📍 California · Delaware · Florida · Illinois · Kentucky · Massachusetts · New Mexico · New York
NCT05920356 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
Atopic Dermatitis
Apogee Therapeutics, Inc. · started 2025-05-14
📍 California · Florida · Georgia · Illinois · Kentucky · Michigan · New York · North Carolina
NCT07003425 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Ovarian Cancer
AbbVie · started 2025-11-13
📍 California · Florida · Kentucky · Louisiana · Maine · Massachusetts · Michigan · Montana
NCT07059845 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC · started 2026-01-29
📍 California · Colorado · Florida · Kentucky · Missouri · New Jersey · Oregon · South Dakota
NCT07227597 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Breast Neoplasms
Eli Lilly and Company · started 2026-05-13
📍 Alabama · Arizona · California · Colorado · Florida · Georgia · Indiana · Kentucky
NCT07287098 on ClinicalTrials.gov ↗
Recruiting Phase 3
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Crohn's Disease, Obesity or Overweight
Eli Lilly and Company · started 2025-06-26
📍 Alabama · California · Florida · Idaho · Illinois · Indiana · Kentucky · Louisiana
NCT06937099 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
Asthma
Eli Lilly and Company · started 2025-10-22
📍 Arizona · California · Colorado · Florida · Illinois · Kentucky · Massachusetts · Nevada
NCT07219173 on ClinicalTrials.gov ↗
Recruiting Phase 2
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC · started 2021-04-05
📍 Arkansas · California · Colorado · Kentucky · Minnesota · New Jersey · North Dakota · Texas
NCT04728893 on ClinicalTrials.gov ↗
Recruiting Phase 3
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Lennox Gastaut Syndrome
Epygenix · started 2025-04-09
📍 Arkansas · California · Florida · Illinois · Kentucky · Michigan · Minnesota · Nebraska
NCT05066217 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Episodic Migraine
H. Lundbeck A/S · started 2023-06-08
📍 Connecticut · Florida · Georgia · Kentucky · Maryland · Michigan · New York · North Carolina
NCT05897320 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Chronic Migraine in Children
H. Lundbeck A/S · started 2021-06-30
📍 Connecticut · District of Columbia · Florida · Georgia · Kentucky · Maryland · Michigan · New York
NCT04965675 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ovarian Cancer, Breast Cancer, Endometrial Cancer, Biliary Tract Cancer
NextCure, Inc. · started 2025-01-07
📍 California · Kentucky · Massachusetts · Missouri · New Jersey · New York · Ohio · Pennsylvania
NCT06774963 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study of Brenipatide in Participants With Opioid Use Disorder
Opioid Use Disorder
Eli Lilly and Company · started 2026-02-13
📍 Arizona · Arkansas · California · Florida · Illinois · Indiana · Kentucky · Maryland
NCT07420283 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
AbbVie · started 2024-07-29
📍 California · Kentucky · Maryland · Missouri · Nevada · New Jersey · New York · North Carolina
NCT06365853 on ClinicalTrials.gov ↗
Active Phase 3
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2)
Systemic Lupus Erythematosus
Novartis Pharmaceuticals · started 2023-04-21
📍 Alabama · California · Florida · Georgia · Illinois · Kentucky · Louisiana · Maryland
NCT05624749 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC · started 2021-05-12
📍 Arizona · California · Colorado · District of Columbia · Florida · Kansas · Kentucky · Maryland
NCT07218029 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Sanofi Pasteur, a Sanofi Company · started 2024-04-05
📍 Arizona · California · Florida · Georgia · Illinois · Indiana · Iowa · Kentucky
NCT06316297 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Merck Sharp & Dohme LLC · started 2024-04-03
📍 Arkansas · California · Connecticut · Florida · Georgia · Illinois · Indiana · Kentucky
NCT06312137 on ClinicalTrials.gov ↗
Recruiting Phase 3
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Metastatic Colorectal Cancer
Amgen · started 2024-07-17
📍 Arizona · California · Connecticut · Florida · Georgia · Illinois · Kentucky · Michigan
NCT06252649 on ClinicalTrials.gov ↗
Active Phase 2
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC · started 2022-07-21
📍 Alaska · Arizona · Colorado · Illinois · Kansas · Kentucky · Maryland · Massachusetts
NCT05458297 on ClinicalTrials.gov ↗
Active Phase 2
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis
Moderate to Severe Atopic Dermatitis
Nektar Therapeutics · started 2023-11-15
📍 Arkansas · California · Florida · Georgia · Indiana · Kentucky · Michigan · Nevada
NCT06136741 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 112 Florida · 111 Georgia · 60 Colorado · 54 Arizona · 53 Illinois · 48 New York · 44 Massachusetts · 41 Connecticut · 38 Alabama · 37 Michigan · 30 Indiana · 27 Maryland · 27 Ohio · 26 Arkansas · 23 Kentucky · 21

Browse by condition

Prostate Cancer · 5 Ovarian Cancer · 4 Overweight · 4 Obesity · 4 Systemic Lupus Erythematosus · 3 Ulcerative Colitis · 3 Follicular Lymphoma · 3 Heart Failure · 3 Non-small Cell Lung Cancer · 3 Lymphoma, Large B-Cell, Diffuse · 2 Diabetes Mellitus, Type 1 · 2 Breast Neoplasms · 2 B-cell Malignancy · 2 Hidradenitis Suppurativa · 2 Acute Myeloid Leukemia · 2 Ovarian Neoplasms · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/kentucky (Accessed: 22 August 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.